Rubeosis iridis and macular hemorrhages from multiple Corkscrew retinal vessels in a patient with NF1

Abstract

Purpose:

To report a case of a patient with NF1 presenting with ocular findings of AV malformation, multiple retinal hemorrhages, and neovascular glaucoma in the absence of retinal ischemia.

Methods:

Review of the medical record was conducted in accordance with the local IRBt.

Results:

A 60-year-old female patient with diagnosis of Neurofibromatosis type1 (NF1) and sudden decrease of vision in her left eye was found to have rubeosis iridis and high intraocular pressure (IOP). On fundus exam multiple corkscrew retinal vessels and retinal hemorrhages were present in her left eye. On Optical Coherence Tomography (OCT) the foveal hemorrhages appeared as outer layer hyperreflective retinal infiltrates whereas in the parafoveal area the hyperreflectivity was present between the RPE and neurosensory retina. Fluorescein Angiogram (FA) showed normal perfusion and no areas of leakage or ischemia. Treatment with anti-angiogenics in a timely manner correlated with a good visual outcome.

Conclusions:

We present a unique patient with NF1, rubeosis iridis, high IOP, and macular hemorrhages from multiple corkscrew retinal vessels in a well perfused retina, who underwent treatment with a single dose of intravitreal Bevacizumab and had an excellent response

Keywords

Corkscrew retinal vessels intravitreal bevacizumab neovascular glaucoma neurofibromatosis type 1 Rubeosis iridis

Get full access to this article

View all access options for this article.

References

Friedman

Guttman

Mac Collin

, et al (eds). Neurofibromatosis: phenotype, natural history, and pathogenesis. 3rd ed. Baltimore, MD: Johns Hopkins University Press, 1999.

Shields

Pellegrini

Kaliki

, et al. Retinal vasoproliferative tumors in 6 patients with neurofibromatosis type 1. JAMA Ophthalmol 2014; 132(2): 190–196.

Parrozzani

Pilotto

Clementi

, et al. Retinal vascular abnormalities in a large cohort of patients affected by neurofibromatosis type1: a study using optical coherence tomography angiography. Retina 2018; 38(3): 585–593.

Al Freihi

Edward

Nowilaty

, et al. Iris neovascularization and neovascular glaucoma in neurofibromatosis type 1: report of 3 cases in children. J Glaucoma 2013; 22: 336–341.

Muci-Mendoza

Ramella

Fuenmayor-Rivera

Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases. Br J Ophthalmol 2002; 86: 282–284.

Lubinsky

MS.

Non-random associations and vascular fields in neurofibromatosis 1: a pathogenetic hypothesis. Am J Med Genet A 2006; 140(19): 2080–2084.

Boley

Sloan

Pemov

, et al. A quantitative assessment of the burden and distribution of Lisch nodules in adults with neurofibromatosis type 1. Invest Ophthalmol Vis Sci 2009; 50(11): 5035–5043.

Makino

Endoh

Tampo

Retinal microvascular abnormalities in neurofibromatosis type 1 associated with congenital retinal macrovessels. Case Rep Ophthalmol Med 2013; 2013: 604191

Moramarco

Miraglia

Mallone

, et al. Retinal microvascular abnormalities in neurofibromatosis type 1. Br J Ophthalmol 2019; 103(11): 1590–1594.

10.

Hamilton

Friedman

JM.

Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 2000; 58(5): 341–344.

11.

Bajaj

Zheng

, et al. Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis. PLoS One 2012; 7(11): e49222.

12.

Zhang

Hudson

, et al. Neurofibromin deficiency induces endothelial cell proliferation and retinal neovascularization. Invest Ophthalmol Vis Sci 2018; 59(6): 2520–2528.

13.

Sharafi

Ayter

Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes. J Neurogenet 2018; 32(2): 65–77.

14.

Nourinia

Motevasseli

Tofighi

Intravitreal bevacizumab role in the treatment of macular edema secondary to retinal vasoproliferative tumor in a patient with neurofibromatosis type 1. GMS Ophthalmol Cases 2016; 6: Doc08.